Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2013-12-20

Acipimox only to be used as additional or alternative treatment to reduce high triglyceride levels

View source ↗

Summary

The EMA announces that acipimox should be used only as an additional or alternative treatment to reduce high triglyceride levels, not as a first-line or standal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acipimox (Acipimox)